Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1998 | 12-1997 | 09-1997 | 06-1997 | 03-1997 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38,640 | 40,130 | 42,162 | 42,206 | 42,741 |
| Receivables | 260 | N/A | 0 | 0 | 0 |
| Other current assets | 370 | 0 | 1,043 | 874 | 405 |
| TOTAL | $39,270 | $40,130 | $43,205 | $43,080 | $43,146 |
| Non-Current Assets | |||||
| PPE Net | 460 | N/A | 299 | 218 | 148 |
| Other Non-Current Assets | 80 | 0 | 80 | 80 | 80 |
| TOTAL | $540 | $N/A | $379 | $298 | $228 |
| Total Assets | $39,670 | $41,150 | $43,491 | $43,308 | $43,317 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,360 | 0 | 1,214 | 893 | 722 |
| Other current liabilities | 50 | N/A | 25 | 22 | 707 |
| TOTAL | $1,420 | $N/A | $1,239 | $915 | $1,429 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,420 | $950 | $1,239 | $915 | $1,429 |
| Shareholders' Equity | |||||
| Common Shares | 100 | N/A | 101 | 99 | 93 |
| Retained earnings | -27,340 | N/A | -23,024 | -21,462 | -19,034 |
| Other shareholders' equity | 200 | 40,200 | -90 | -92 | -94 |
| TOTAL | $38,240 | $40,200 | $42,252 | $42,393 | $41,888 |
| Total Liabilities And Equity | $39,660 | $41,150 | $43,491 | $43,308 | $43,317 |